Compartmentation of B lymphocyte populations is associated with differences in both development stage and sensitivity to Ig (sIg)-dependent triggering. In order to characterize the factors that contribute in setting the level of sensitivity of a B cell, we quantified sIgM-dependent regulation of Ig secretion in purified mature and immature B cells after ex vivo and in vivo modification of their environment. These analyses formally demonstrate that the bone marrow (BM) microenvironment locally induces high B cell sensitivity to sIgM ligation irrespective of differentiation stage. We further provide evidence that BM macrophages create a dominant environment that enhances B cell sensitivity to B cell receptor triggering. Finally, using ex vivo assays as well as type I IFN receptor-deficient mice we show that IFN-β produced by resident BM macrophages is necessary and sufficient to define B cell sensitivity. Implications of these findings for the understanding of B cell selection processes are discussed.
Introduction
In adult mice, B lineage cells are generated and develop in the bone marrow (BM). Upon expression of membrane IgM (sIgM) differentiating cells reach the immature B lymphocyte stage, while expression of sIgD defines mature B cells (1) that become independent of stromal cells and enter the sinusoids to leave the marrow and populate peripheral organs.
Engagement of the clonal B cell receptor (BCR) or its surrogate is likely to be an important event in the differentiation of B lymphocytes, as suggested by the arrest in B cell development in several mutants that fail to express sIgM (2) (3) (4) (5) (6) (7) . BCR occupancy and the ensuing cascade of biochemical events (8, 9 ) differentially affect B cell survival, activation and effector functions, ranging from terminal differentiation to apoptosis. This is illustrated by the differences found in the Ig V region repertoires of B cell populations emerging in BM versus those in the periphery, either resting or activated and secreting Ig at a high rate (10) . Analyses of transgenic mice expressing a BCR binding to multivalent self-antigens such as cell surface molecules and DNA have established that such autoreactive specificities are eliminated in the BM (11) (12) (13) (14) (15) (16) . B cell functional impairment was instead observed when the transgenic BCR was ligated by soluble, monomeric autoantigens (17) (18) (19) . Consistently, increasing experimental evidence that involved analyses of mutant mice for one element of the sIgM signaling cascade (20) (21) (22) (23) or for coreceptors molecules (24) (25) (26) (27) (28) (29) (30) supports the idea of a threshold model of B cell response after antigen encounter.
Several in vitro studies have discriminated the sensitivity of immature and mature B cells. A conventional assay thought to represent an in vitro correlate of autoreactive B cell elimination is BCR ligation-induced apoptosis. Cross-linking of sIgM leads to apoptosis of immature but not of mature B cells (31) , although mature B cell apoptosis after 'hyper-cross-linking' of sIg has been described (32) . Numerous studies suggest that surface IgD expression correlates with B cell resistance to deletion upon interactions with antigen (reviewed in 33). However, several controversial observations have been generated with such a readout. Thus, BM immediate emigrants with an IgM ϩ IgD ϩ phenotype have been shown to be still hypersensitive to sIgM ligation (34) . Alternatively, transitional IgM bright B cells in the BM have been described as more sensitive to elimination than bona fide immature B cells (35) . Finally, peripheral deletion of self-reactive mature B lymphocytes may occur if the cells encounter membranebound antigen at a post-BM stage of development (36) Another model system for studies on B cell sensitivity to BCR engagement is the inhibition of lipopolysaccharide (LPS)-induced terminal differentiation and Ig secretion by sIgM ligation (37) . If B cells are exposed to LPS while sIgM is cross-linked [being with anti-IgM or (Fab) 2 fragments], their proliferative response is not affected but the responding cells fail to secrete IgM, as also reflected in a total loss of J chain mRNA, a retention of processing of µm mRNA (38, 39) and a decrease in transcriptional activity at the Ig heavy chain locus (40) . This functional state thus resembles non-secreting blast cells that represent the large majority of naturally activated B lymphocytes (41) and share phenotypical characteristics with 'anergic' B cells (42) . This experimental system presents a number of advantages as compared to other assays of B cell sensitivity. Thus, it concerns the entire B cell compartment, even in normal mice, since LPS activates all B cells and antiIg is a universal ligand for B cells that is functionally equivalent to multivalent nominal antigen binding (43) . Moreover, suppression is detectable with a physiologically relevant concentration of anti-IgM antibody (1-100 ng/ml), is ligand concentration dependent and the system allows for precise quantitation of B cell sensitivity.
In a previous study, we evaluated the sensitivity to suppression of B cells isolated from various compartments and have shown that BM-derived B cells are~100-fold more sensitive than splenic, peritoneal or circulating B cells (44) . Surprisingly, we found that in vitro generated B cells display a maturetype sensitivity despite their immature phenotype. Moreover, we showed that supernatant from total BM culture induces a high level of sensitivity in such a B cell population. These results suggested that the stage of differentiation per se does not define the threshold of sensitivity of B cells to BCR ligation and that some BM-specific factor(s) modulate B cell sensitivity. While positive and negative effects of stroma cells and cytokines on early B cell lineage development as well as on late differentiation events (class-switch) have been extensively investigated (reviewed in 45, 46) little is known on environmental effects on intermediate stages of maturation.
In order to characterize the factors that contribute to setting the level of sensitivity of B cells in vivo, we investigated the sensitivity of purified immature and mature B cells isolated from the same compartment or after modification of their environment. These analyses lead us to formally demonstrate that the BM compartment defines the threshold of B cell sensitivity regardless of their differentiation stage. Moreover, we found that IFN-β produced by BM macrophages is the responsible modulator of B cell sensitivity. These novel findings should contribute to our understanding of the B lymphocyte selection processes.
Methods

Mice
All experiments involving normal mice were done on C57Bl/ 6 purchased from Iffa-Credo (l'Abresle, France) excepted for the co-cultures that involved the congenic CB20 obtained from our mouse facilities. IFN-αβ receptor-deficient mice, a gift from Michel Aguet, and control 129Sv wild-type animals were bred in our animal facilities. All mice were analyzed between 6 and 12 weeks of age. Treatment with hydroxyurea (HU) was performed as described previously (47): HU (Sigma, St Louis, MO) was dissolved in 0.9% NaCl and administrated i.p. as two doses of 1 mg/g body wt/day, injected 7 h apart for 4 days.
Cell purification and cultures
Cell suspensions were prepared by grinding spleens between frosted ends of glass slides or by flushing whole BM from bones with a 23 gauge needle. In vitro differentiated B cells were generated as described elsewhere (44) . All cultures were perform in RPMI 1640 (Gibco/BRL, Gaithersburg, MD) supplemented with 10% FCS (Boehringer Mannheim, Meylan, Germany), 5ϫ10 -5 M β 2 -mercaptoethanol and antibiotics (all from Gibco/BRL), except for pre-B cells where RPMI was replaced with OPTI-MEM media (Gibco/BRL). Cell density was kept as 10 6 /ml unless otherwise specified in the text. Cocultures of spleen and BM cells, as well as pre-incubations with supernatant or cytokines lasted for 48 h before LPS induction. Pre-incubation with culture supernatant was done as a 2:1 dilution in fresh media. Suppression assay was performed as previously described (43) . Briefly, cells were seeded in triplicate in 96-well plates in the presence of different concentrations of monoclonal anti-µ. After 1-2 h, 25 µl of LPS from Salmonella typhimurium (Difco, St Louis, MO) was added and the cells harvested on day 4 for cellular assay of IgM secretion by ELISA spot assay (ESA) (see below). For each experiment, a duplicate plate was set up for [ 3 H]thymidine uptake on day 2, such as to control for LPS-induced proliferation.
Cytokines and antibodies
Inhibition of LPS-induced differentiation was done using mAb against IgM produced in the laboratory from 331 hybridoma. For ESA, coating was done by using polyclonal goat anti-mouse IgM, secondary antibody was polyclonal goat anti-IgM-alkaline phospatase, both purchased from Southern Biotechnology Associates (Birmingham, AL). mAb specific for µa or µb chains were produced in the laboratory from hybridomas RS3.1 and MB86 respectively. For panning, polyclonal goat anti-mouse IgM µ chain-specific antibodies were obtained from Sigma. Neutralizing mAb against mouse IFN-β was purchased from JIMCEN (Tokyo, Japan). For flow cytometry and cell separation, monoclonal RA3-6B2 B220/CD45 phycoerythrin (PE)-conjugated, biotin-CD23 and biotin-MAC1 were purchased from PharMingen (San Diego, CA). PE-IgD was obtained from Southern Biotechnology Associates and polyclonal IgM, µ chain specific, fluorescein-conjugated from Pierce (Rockford, IL). Mouse fibroblast IFN-αβ was purchased from Sigma.
Cell separation and flow cytometry
Cell separation was performed by miniMACS magnetic sorting according to the manufacturer's protocol (Miltenyi Biotec, Bergisch-Gladbach, Germany). For immature and mature B cell purification, total BM or erythrocyte-depleted spleen cells were stained with biotin-labeled anti-CD23. Positive and negative fractions were collected. For immature BM B cells, the negative fraction was used as such or after a second step of positive purification using biotinylated B220 antibody. For macrophage enrichment, total BM cells were stained with anti-MAC1 antibody and the positive fraction was collected. B lineage depletion was done by collection of the negative fraction after labeling of total BM cells with biotinylated B220. For all negative selections, cells were passed twice sequentially on two different columns. In all cases purity of the cells was Ͼ90%. Flow cytometry analyses were performed as described elsewhere (48) . Biotin-conjugated mAb were revealed with streptavidin-TriColor (Caltag, San Francisco, CA). Data were collected from 5-10ϫ10 3 cells on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA) and data analyses were performed using the CellQuest program.
ESA
IgM-secreting cells were enumerated using a modification of the Sedgwik and Holt technique (48, 49) . Briefly, flat-bottomed ELISA plates were coated with polyclonal anti-mouse IgM antibodies or monoclonal anti-allotype antibodies. LPSinduced cells were washed twice and resuspended in RPMI containing 2% FCS. One-third serial dilutions were distributed in the microwells and incubated at 37°C for 4 h. After cell lysis and extensive washing, secreted IgM were revealed by alkaline phosphatase-conjugated goat anti-mouse IgM antibody followed by 5-bromo-4-chloro-3-indolyl phosphate treatment (Sigma) diluted in 2-amino-2-methyl-1-propenolol buffer (Merck, Darmstadt, Germany). Spots were enumerated and results expressed as a percentage of IgM-secreting cells induced after LPS treatment alone. 
Results
BM resident immature and mature B lymphocytes display similar sensitivities to sIg ligation
There are two types of sIgM ϩ B cells in BM: newly generated immature B220 low , IgD -, CD23 -B cells, and a population of B220 high , IgD ϩ , CD23 ϩ mature cells that include recirculating peripheral B cells and, most likely, lymphocytes that matured in situ. All spleen B cells, on the other hand, display the mature phenotype, even though expression of both IgD and CD23 are down-regulated after activation (50, 51) . In order to directly test the sensitivity to sIgM ligation of immature and mature B cells originating from the same environment, these two populations were isolated from C57Bl/6 BM and their respective susceptibility quantified. To avoid uncontrolled BCR triggering, cell purification was done on the basis of the late differentiation marker CD23. As there is no available discriminating marker for immature B cells, negative selection for the CD23 marker followed by positive selection for B220 ϩ cells allowed the co-isolation of pre-B (B220 ϩ , IgM -) and immature B (B220 ϩ , IgM ϩ , CD23 -) lymphocytes. Figure 1(A) shows the results of such purifications and the corresponding IgD expression. Only 20% of CD23 -immature sorted lymphocytes express IgD, corresponding to the IgM ϩ IgD ϩ intermediate BM population previously described (34) , while a large majority of the B220 ϩ CD23 ϩ cells tested positive for sIgD expression.
The sensitivity of these populations to BCR triggering was thereafter quantified in the assay for IgM-dependent inhibition of LPS-induced Ig secretion. As can be seen in Fig. 1(B) , enriched B220 ϩ CD23 -and B220 ϩ CD23 ϩ BM B cell populations display the same high sensitivity that is characteristic of unsorted total BM cells. In contrast, splenic B cells tested in parallel display a typical low sensitivity dose-response curve (Fig. 1B) , the same low sensitivity being scored with sorted B220 ϩ CD23 ϩ spleen cells (data not shown). Moreover, despite their immature phenotype (2% CD23 ϩ , 20% IgD ϩ ), B lymphocytes that had differentiated from isolated pre-B cells in vitro respond just like peripheral mature B cells, i.e. with low sensitivity to BCR triggering (44) . For both BM and spleen lymphocytes, we confirmed that the labeling of the cells with either B220 and/or CD23 antibodies does not modify the respective dose-response curves in the assay (data not shown).
We conclude that, regardless of their differentiation stage, BM resident B lymphocytes are highly sensitive to sIgM ligation when compared to spleen cells or to immature B cells that differentiated on cloned stromal cells in vitro.
Macrophage-derived factors create a dominant environment that enhances B cell sensitivity to BCR triggering
In a previous work we showed that BM cell culture supernatants induce a high level of sensitivity of in vitro differentiated immature B cells (44) . We therefore investigated the relative contribution of BM and splenic environment in setting the level of sensitivity of normal B lymphocytes.
As a first step, we studied 48 h co-cultures of bulk spleen and BM cells originating from C57/Bl6 (IgM b ) mice and the congenic CB20 (IgM a ) strain respectively. Because of the discrepancy in B cell representation in both organs (60% in the spleen, 15% in the BM), the ratio of spleen versus BM cells was 1:2. Sensitivity of either population was thereafter assayed using allotype-specific mAb. As shown in Fig. 2(A) , BM B cells displaying the same high sensitivity have then been cultured alone or together with spleen cells. In contrast, even though spleen B cell sensitivity is not affected by the 48 h culture per se, when mixed with BM-derived cells they acquire a higher sensitivity that translates as a 1 log difference in the inhibition curve. Similar data where obtained after HU treatment in vivo where peripheral cells are the only B lymphocytes present in BM (52) . These cells display a mature phenotype, yet they acquire a high sensitivity phenotype similar to that of normal BM B cells (Fig. 2B) . These results indicate that the BM compartment provides a dominant environment that enhances mature B cell sensitivity to sIgM ligation.
Two cellular components in the BM could be responsible for the induction of increased B cell sensitivity, i.e. stromal cells and macrophages. Stromal cell lines allow growth and differentiation of pre-B and B cells in vitro but, as seen above, in vitro differentiated B cells under such conditions display a low-sensitivity phenotype. On the other hand, BM resident macrophages have been shown to modulate pre-B cell growth (53) and seemed good candidates for mediating B cell sensitivity. To asses these possibilities we designed a set of experiments in which spleen cells were co-incubated with BM cells that had been enriched for either macrophages (purification on the basis of Mac-1 surface marker expression) or both stromal cells and macrophages (B220 -, i.e. B lineage cell depletion). Surface expression of Mac-1 is found on the majority of polynuclear neutrophils and macrophages, but the latter survive preferentially in culture (54) . Ratios of spleen to BM cells were 1:1 in the Mac-1 ϩ co-cultures and 1:2 in the B220 -protocol. Results of the purifications are shown in Fig.  2(C) . As can be seen in Fig. 2(D) , the sensitivity to BCR triggering of splenic B cells was equally increased after 48 h co-cultures with either BM population. In another set of experiments, splenic cells or in vitro differentiated immature B cells were co-cultured for 48 h with supernatants of either bulk BM culture or Mac-1 ϩ -enriched culture. The sensitivity of such treated B cells is greatly enhanced and was identical to that of lymphocytes co-cultured with Mac-1 ϩ cells (data not shown).
Taken together, these results suggest that BM resident macrophages secrete a diffusible factor that can enhance mature and immature B cell sensitivity to sIgM ligation.
B cell sensitivity to sIgM ligation can be modulated by IFN-αβ treatment
Numerous cytokines are secreted by resident BM macrophages, but one of them, IFN-β, has been recently reported to control pre-B cell proliferation in situ (53) . Considering therefore that type 1 IFN could be a candidate for a B cell sensitivity modulation factor, we monitored the LPS/anti-µ response of mature (splenic) and immature (in vitro differentiated) B cells after 48 h culture in the presence of IFN-αβ at various concentrations. Strikingly, this procedure drastically enhanced B cell sensitivity to BCR triggering-spleen cells treated with only 100 U/ml IFN-αβ displaying the same doseresponse to sIgM ligation as BM B cells (Fig. 3A) . Consistently, the sensitivity of in vitro differentiated B cells was found to increase equally much after type 1 IFN treatment (Fig. 3B) . In both cases, IFN-αβ treatment did not affect survival, proliferative response or sIgM expression (data not shown). These results demonstrate that type 1 IFN alone can induce B cells to modify their sensitivity threshold to sIgM ligation.
IFN-β is the cytokine responsible for local modulation of BM B cell sensitivity
To determine whether type 1 IFN is the cytokine that creates the selective, high-sensitivity BM environment, we followed two complementary approaches. First, we treated ex vivo bulk BM cells with neutralizing antibodies to IFN-β for 48 h and tested the sensitivity of the respective B cells. As shown in Fig. 4(A) , BM B cells deprived of IFN-β become more resistant to the anti-µ treatment, undergoing therefore what could be designated by a reversion in sensitivity. Further evidence for the key role of the type 1 IFN in this process is provided by the analyses of the IFN-αβ receptor-deficient mice (55) . These mice display a normal steady-state cellularity and, more particularly, a normal ratio of immature to mature B lymphocytes in the BM (not shown). However, when tested in the sIgM-dependent assay, BM B cells from mutant mice display a low-sensitivity phenotype (Fig. 4B) that is comparable to peripheral cells of either animal. Together, these results formally prove that IFN-β is strictly required to sensitize B cells in the BM to low thresholds of sIgM triggering.
Discussion
The present results establish that B cell sensitivity to IgM receptor ligation is not an intrinsic property of the cell determined by its stage of differentiation, but a variable response to environmental factors. Furthermore, we show that IFN-β is sufficient and necessary to enhance the sensitivity of any B cell type. Finally, we provide evidence that IFN-β production by resident BM macrophages determines the high levels of sensitivity that characterize BM B cells of normal animals.
As our conclusions are at variance with the prevalent conviction that sensitivity to receptor ligation follows the genetic program of B lymphocyte differentiation, we should first validate our experimental approach. This differs from previously used systems in several respects. First, instead of studying transformed cell lines in vitro, we analyzed normal B cells in vivo or ex vivo. Second, we have separated immature and mature B cells in BM by labeling techniques that did not involve ligation of sIgM or sIgD; this has not been the case in earlier studies. Finally, our assay for scoring sensitivity to BCR ligation requires physiological relevant ligand concentrations (1-100 ng/ml); these are orders of magnitude lower than those (5-50 µg/ml) used in conventional read-outs, such as apoptosis, proliferation or calcium flux.
B cell sensitivity is determined by their microenvironment, irrespective of differentiation stage
The present observations unequivocally demonstrate that B cell differentiation stage does not correlate with threshold of sensitivity to sIgM ligation. Thus, BM resident B cells, regardless of their immature or mature phenotype, display equivalent sensitivity that is 50-fold higher than that of splenic B cells.
The results also clearly establish that B cell sensitivity depends upon the microenvironment where the cells reside. Thus, after HU treatment in vivo, peripheral cells with a mature phenotype are the only B lymphocytes present in BM; yet, these cells acquire a high-sensitivity phenotype similar to that of normal BM B cells. Furthermore, the co-culture experiments show that BM cells create a 'dominant' environment that enhances splenic B cell sensitivity. In this ex vivo system, the sensitivity of peripheral B cells does not quite reach the high levels of BM B cells. This may result from the loss of the BM structural organization in culture or from dilution of cells or factors implicated in the process. We do not formally exclude that maturation stage could be intrinsically associated with subtle differences in sensitivity, within a wider frame that is defined by the microenvironment. Thus, mature B cells isolated from the BM seem slightly less sensitive (2-fold) than the corresponding immature B cells. Both populations, however, are up to 50-fold more sensitive than B cells deprived of the BM environment (splenic or in vitro generated). In order to ascertain those minor differences, potentially associated with differentiation stage, novel highly sensitive assays will be required.
Macrophage-produced IFN-β sets the sensitivity of BM resident B cells
Our ex vivo experiments indicated that factors secreted by BM cells are responsible for enhancing B cell sensitivity. We then showed that recombinant type 1 IFN alone is enough to induce physiological modulation and, by antibody neutralization ex vivo, further proved that IFN-β is the cytokine responsible for the specific BM environment. Previous studies have established that the resident population of BM macrophages is the principle source of secreted type 1 IFN (53, 54, 56 Analyses of mutant mice suggest that the threshold of B cell sensitivity may be modulated by an intracellular mechanism that affects antigen receptor signaling in B lymphocytes (20) (21) (22) (23) . Similarly, triggering of co-stimulatory molecules like CD40 (58, 59) or co-receptor molecules like CD19 or CD22 (60-62) have been involved in the induction of a physiological state that would modulate the cell response upon antigen encounter. Finally, regulatory genes could been involved in the quality of a B cell response; thus, blimp expression correlates with maturation to Ig secretion (63) and is downregulated in anti-µ suppressed cells (64) .
We propose, therefore, that upon exposure to IFN-β, B cells are induced to a state of higher responsiveness to BCR triggering. This 'pre-responsive state' could be determined by phosphorylation of one element of the cascade that follows sIgM ligation, implying overlaps in the IFN-αβ receptor and sIgM signaling pathways which have not yet been established. On the other hand, regulation could operate at the transcriptional level. Experiments aimed at defining these alternatives are in progress.
Modulation of the threshold of sensitivity and B cell selection
It is widely accepted that B lymphocytes with high affinity for multivalent self antigens are eliminated early in their genesis. Additional control has been found in transgenic models for low-affinity antigens and defined as 'anergy'. Therefore, two types of 'negative selection' of B cells have been described, each involving differential levels of sIgM triggering. In apparent contradiction, current views also accommodate the notion that BCR ligation also induces activation and leads to terminal differentiation (reviewed in 24, 33) . Finally, a good number of recent works addressing the function of BCR co-receptor molecules (24) (25) (26) (27) (28) (29) (30) or components of the sIgM signal transduction pathway (20) (21) (22) (23) revealed that changes in the threshold of sensitivity or in the signal intensity modify the nature of B cell responses to antigen encountering. Such studies are therefore consistent with a signal-threshold model for B cell selection and progression of differentiation. Assuming that the response of a B cell to interaction with antigen is dependent on quantitative, rather than qualitative aspects of BCR ligation, the nature of the response would simply follow a gradient of stimulation. In such a quantitative model, low-level ligation is associated with survival, higher levels induce activation, while yet higher levels result in activated cells that are suppressed in terminal differentiation ('anergic'). Finally, very high levels of BCR ligation induce apoptosis. Therefore, the fate of a B cell is a combination of antigen encounter (affinity, multivalence, concentration) and its threshold of sensitivity. That the compartment where B cells are generated offers conditions of highest sensitivity would ensure a stringent control of B cell production. In the periphery all types of responses can be found and local modulation of the threshold of B cells, e.g. when interacting with T cells, would allow a specific response. Further studies, involving analyses of selection events in the IFN-αβ receptor-deficient mice, should provide a better understanding on the impact of sensitivity modulation in the composition of the B cell compartment.
